Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Preimplantation Genetic Diagnosis in Blocking Pathogenic Gene Inheritance for Autosomal Dominant Polycystic Kidney Disease: a Multicenter Clinical Trial

NCT02948179 is registered in ClinicalTrials.gov with Changlin Mei as lead sponsor.

NCT NCT02948179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02948179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Preimplantation Genetic Diagnosis in Blocking Pathogenic Gene Inheritance for Autosomal Dominant Polycystic Kidney Disease: a Multicenter Clinical Trial
Lead sponsor
Changlin Mei
Phase
Not applicable
Overall status
Completed
Start date
September 2, 2016
Completion date
December 31, 2020
Enrollment
459 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic kidney, type 1 autosomal dominant disease